Adult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth

Summary

The leading business intelligence provider GBI Research has released its latest research report, entitled “Adult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth”. The report provides insights into the vaccines in the adult and adolescent vaccines market, including market forecasts up to 2018. It provides an in-depth analysis of the vaccines for the adult and adolescent market, as well as insights into the adult and adolescent vaccines market’s Research and Development (R&D) pipeline. The report provides in-depth analysis of the unmet needs, drivers and barriers that affect the global adult and adolescent vaccines market. The report analyzes the market for adult and adolescent vaccines in the US, and the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. The report discusses the global pipeline for adult and adolescent vaccines across various stages of development. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

GBI Research found that the adult and adolescent vaccines market in the top seven markets was valued at $7.2 billion in 2011, increasing at a Compound Annual Growth Rate (CAGR) of 6.9% during the 2007–2011 historic period. The market is projected to witness a growth of 5.6% during the 2011–2018 forecast period to reach $10.5 billion. The growth in the adult and adolescent vaccines market is driven by increased uptake of pneumococcal vaccines such as Prevnar 13 which got approved for use in people aged 50 and older. The pneumococcal vaccines market is expected to grow at a CAGR of 19% during the forecast period and reach $1.7 billion in 2018, from $0.5 billion in 2011.

Scope

- Annualized market data for the adult and adolescent vaccines market from 2007 to 2011, forecast forward to 2018
- Analysis of the adult and adolescent vaccines market in the leading geographies of the world, which includes the US, the UK, Germany, France, Italy, Spain, and Japan
- Market characterization of the adult and adolescent vaccines market including market size and cost of vaccination
- Key drivers and barriers that have a significant impact on the market
- Coverage of pipeline molecules in various phases of vaccine development
- Competitive benchmarking of leading companies. Key companies studied in this report are GlaxoSmithKline, Sanofi, Pfizer, Merck and Novartis.
- Key M&A activities and licensing agreements that have taken place between 2009 and up to November 2012 in the global adult and adolescent vaccines market.

Reasons to buy

- Align your product portfolio to the markets with the highest growth potential
- Develop market-entry and market expansion strategies by identifying the potential regions and adult and adolescent vaccines market segments poised for strong growth
- Create a more specifically-tailored country strategy through the understanding of key drivers and barriers of the global adult and adolescent vaccines market
- Develop key strategic initiatives by understanding the key focus areas and top-selling products of leading companies
- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

Table Of Contents

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 8
1.2 List of Figures 12
2 Adult and Adolescent Vaccines Market to 2018 - Introduction 14
2.1 Overview 14
3 Adult and Adolescent Vaccines Market to 2018 - Overview 15
3.1 Vaccine Preventable Diseases 15
3.1.1 Types of Vaccines 16
3.2 Recommendations for Immunization 17
3.2.1 The US 17
3.2.2 Top Five European Countries 19
3.2.3 Japan 20
3.3 Regulatory Framework 21
3.3.1 The US 21
3.3.2 Top Five European Countries 22
3.3.3 Japan 23
3.4 Vaccine Manufacturing Process 24
4 Adult and Adolescent Vaccines Market to 2018 - Market Characterization and Forecast 25
4.1 Revenue Forecast 25
4.2 Market Share by Type of Vaccines 27
4.3 Market Share by Geography 28
4.4 Drivers 28
4.4.1 Adult Vaccines Segment to Drive Future Growth 28
4.4.2 High Unmet Needs 28
4.4.3 Targeting New Diseases Areas for Vaccines Likely To Drive the Market 29
4.4.4 Novel Vaccine Technologies 29
4.5 Restraints 30
4.5.1 Production Capacity Limitations 30
4.5.2 High Initial Capital Investments and Technical Expertise 30
4.5.3 Regulations Delay Vaccine Launch and Acceptance 30
5 Adult and Adolescent Vaccines Market to 2018 - Influenza Vaccines 31
5.1 Disease Overview 31
5.2 Market Forecasts 32
5.2.1 The US 32
5.2.2 Top Five European Countries 34
5.2.3 Japan 36
5.3 Cost of Vaccination 37
5.3.1 The US 37
5.3.2 Top Five European Countries 37
5.3.3 Japan 38
5.4 Pipeline Analysis - Influenza Vaccines 39
6 Adult and Adolescent Vaccines Market to 2018 - Tetanus, Diphtheria and Pertussis Vaccines 42
6.1 Disease Overview 42
6.2 Market Forecasts 43
6.2.1 The US 43
6.2.2 Top Five European Countries 44
6.2.3 Japan 46
6.3 Cost of Vaccination 47
6.3.1 The US 47
6.3.2 Top Five European Countries 47
6.3.3 Japan 48
6.4 Pipeline Analysis - Tetanus, Diphtheria, Pertussis (Td/Tdap) Vaccines 49
7 Adult and Adolescent Vaccines Market to 2018 - Pneumococcal Vaccines 50
7.1 Disease Overview 50
7.2 Market Forecasts 51
7.2.1 The US 51
7.2.2 Top Five European Countries 53
7.2.3 Japan 55
7.3 Cost of Vaccination 56
7.3.1 The US 56
7.3.2 Top Five European Countries 56
7.3.3 Japan 57
7.4 Pipeline Analysis - Pneumococcal Vaccines 58
8 Adult and Adolescent Vaccines Market to 2018 - Meningococcal Vaccines 60
8.1 Disease Overview 60
8.2 Market Forecasts 61
8.2.1 The US 61
8.2.2 Top Five European Countries 62
8.3 Cost of Vaccination 64
8.3.1 The US 64
8.3.2 Top Five European Countries 64
8.4 Pipeline Analysis - Meningococcal Vaccines 65
9 Adult and Adolescent Vaccines Market to 2018 - Human Papilloma Virus Vaccines 66
9.1 Disease Overview 66
9.2 Market Forecasts 67
9.2.1 The US 67
9.2.2 Top Five European Countries 68
9.2.3 Japan 70
9.3 Cost of Vaccination 71
9.3.1 The US 71
9.3.2 Top Five European Countries 71
9.3.3 Japan 72
9.4 Pipeline Analysis - Human Papillomavirus Vaccines 73
10 Adult and Adolescent Vaccines Market to 2018 - Hepatitis Vaccines 75
10.1 Disease Overview 75
10.2 Market Forecasts 76
10.2.1 The US 76
10.2.2 Top Five European Countries 77
10.2.3 Japan 79
10.3 Cost of Vaccination 80
10.3.1 The US 80
10.3.2 Top Five European Countries 80
10.3.3 Japan 81
10.4 Pipeline Analysis - Hepatitis Vaccines 82
11 Adult and Adolescent Vaccines Market to 2018 - Measles, Mumps and Rubella Vaccines 85
11.1 Disease Overview 85
11.2 Market Forecasts 85
11.2.1 The US 85
11.2.2 Top Five European Countries 87
11.3 Cost of Vaccination 88
11.3.1 The US 88
11.3.2 Top Five European Countries 89
12 Adult and Adolescent Vaccines Market to 2018 - Zoster Vaccines 90
12.1 Disease Overview 90
12.2 Market Forecasts 90
12.2.1 The US 90
12.2.2 The UK 91
12.3 Cost of Vaccination 91
12.3.1 The US 91
12.3.2 The UK 92
12.4 Pipeline Analysis - Zoster Vaccines 92
13 Adult and Adolescent Vaccines Market to 2018 - Varicella Vaccines 93
13.1 Disease Overview 93
13.2 Market Forecasts 93
13.2.1 The US 93
13.2.2 Top Five European Countries 94
13.2.3 Japan 96
13.3 Cost of Vaccination 97
13.3.1 The US 97
13.3.2 Top Five European Countries 97
13.3.3 Japan 98
13.4 Pipeline Analysis - Varicella Vaccines 98
14 Adult and Adolescent Vaccines Market to 2018 - Competitive Landscape 99
14.1 Introduction 99
14.2 Major Company Profiles 99
14.2.1 GlaxoSmithKline 99
14.2.2 Sanofi 101
14.2.3 Pfizer 102
14.2.4 Merck 103
14.2.5 Novartis 104
15 Adult and Adolescent Vaccines Market to 2018 - Strategic Consolidations 105
15.1 Deals by Year 105
15.2 Deals by Type 106
15.3 Deals by Value 107
15.4 Deals by Geography 108
15.5 Summary of Major MandA Deals 109
15.6 Summary of Major Licensing Deals 110
15.7 Summary of Major Partnerships 111
16 Adult and Adolescent Vaccines Market to 2018 - Appendix 113
16.1 Market Definitions 113
16.2 Abbreviations 113
16.3 Bibliography 115
16.4 Research Methodology 115
16.4.1 Coverage 115
16.4.2 Secondary Research 116
16.4.3 Primary Research 116
16.4.4 Model for Estimation of Vaccine Market 117
16.5 Geographical Landscape 119
16.6 Pipeline Analysis 119
16.7 Competitive Landscape 119
16.7.1 Expert Panel Validation 119
16.8 Contact Us 119
16.9 Disclaimer 119

List of Tables

Table 1: Adult and Adolescent Vaccines Market to 2018, Vaccine-preventable Diseases, 2012 15
Table 2: Adult and Adolescent Vaccines Market to 2018, Top Seven Markets, Revenue ($bn), 2007-2011 25
Table 3: Adult and Adolescent Vaccines Market to 2018, Top Seven Markets, Revenue Forecast ($bn), 2011-2018 26
Table 4: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, the US, Revenue ($m), 2007-2011 33
Table 5: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, The US, Revenue Forecast ($m), 2011-2018 33
Table 6: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Top Five European Countries, Revenue ($m), 2007-2011 34
Table 7: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Top Five European Countries, Revenue Forecast ($m), 2011-2018 35
Table 8: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Japan, Revenue ($m), 2007-2011 36
Table 9: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Japan, Revenue Forecast ($m), 2011-2018 36
Table 10: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, the US, Cost of Vaccination ($), 2007-2011 37
Table 11: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, the US, Cost of Vaccination Forecast ($), 2011-2018 37
Table 12: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007-2011 37
Table 13: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011-2018 37
Table 14: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Japan, Cost of Vaccination ($), 2007-2011 38
Table 15: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Japan, Cost of Vaccination Forecast ($), 2011-2018 38
Table 16: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Global, Pipeline by Phase, 2012 40
Table 17: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, the US, Revenue ($m), 2007-2011 43
Table 18: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, the US, Revenue Forecast ($m), 2011-2018 43
Table 19: Adult and Adolescent Vaccines Market to 2018, Td/ Tdap, Top Five European Countries, Revenue ($m), 2007-2011 44
Table 20: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Top Five European Countries, Revenue Forecast ($m), 2011-2018 45
Table 21: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Japan, Revenue ($m), 2007-2011 46
Table 22: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Japan, Revenue Forecast ($m), 2011-2018 46
Table 23: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, the US, Cost of Vaccination ($), 2007-2011 47
Table 24: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, the US, Cost of Vaccination Forecast ($), 2011-2018 47
Table 25: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Top Five European Countries, Cost of Vaccination ($), 2007-2011 47
Table 26: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Top Five European Countries, Cost of Vaccination Forecast ($), 2011-2018 47
Table 27: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Japan, Cost of Vaccination ($), 2007-2011 48
Table 28: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Japan, Cost of Vaccination Forecast ($), 2011-2018 48
Table 29: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Global, Pipeline by Phase, 2012 49
Table 30: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, the US, Revenue ($m), 2007-2011 51
Table 31: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, the US, Revenue Forecast ($m), 2011-2018 51
Table 32: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Top Five European Countries, Revenue ($m), 2007-2011 53
Table 33: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Top Five European Countries, Revenue Forecast ($m), 2011-2018 54
Table 34: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Japan, Revenue ($m), 2007-2011 55
Table 35: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Japan, Revenue Forecast ($m), 2011-2018 55
Table 36: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, the US, Cost of Vaccination ($), 2007-2011 56
Table 37: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, the US, Cost of Vaccination Forecast ($), 2011-2018 56
Table 38: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007-2011 56
Table 39: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011-2018 56
Table 40: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Japan, Cost of Vaccination ($), 2007-2011 57
Table 41: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Japan, Cost of Vaccination Forecast ($), 2011-2018 57
Table 42: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Global, Pipeline by Phase, 2012 59
Table 43: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, the US, Revenue ($m), 2007-2011 61
Table 44: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, the US, Revenue Forecast ($m), 2011-2018 61
Table 45: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, Top Five European Countries, Revenue ($m), 2007-2011 62
Table 46: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, Top Five European Countries, Revenue Forecast ($m), 2011-2018 63
Table 47: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, the US, Cost of Vaccination ($), 2007-2011 64
Table 48: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, the US, Cost of Vaccination Forecast ($), 2011-2018 64
Table 49: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007-2011 64
Table 50: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011-2018 64
Table 51: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, Global, Pipeline by Phase, 2012 65
Table 52: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, the US, Revenue ($m), 2007-2011 67
Table 53: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, the US, Revenue Forecast ($m), 2011-2018 67
Table 54: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Top Five European Countries, Revenue ($m), 2007-2011 68
Table 55: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Top Five European Countries, Revenue Forecast ($m), 2011-2018 69
Table 56: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Japan, Revenue Forecast ($m), 2010-2018 70
Table 57: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, the US, Cost of Vaccination ($), 2007-2011 71
Table 58: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, the US, Cost of Vaccination Forecast ($), 2011-2018 71
Table 59: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007-2011 71
Table 60: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011-2018 71
Table 61: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Japan, Cost of Vaccination Forecast ($), 2009-2018 72
Table 62: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Global, Pipeline by Phase (%), 2012 74
Table 63: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, the US, Revenue ($m), 2007-2011 76
Table 64: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, the US, Revenue Forecast ($m), 2011-2018 76
Table 65: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Top Five European Countries, Revenue ($m), 2007-2011 77
Table 66: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Top Five European Countries, Revenue Forecast ($m), 2011-2018 78
Table 67: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Japan, Revenue ($m), 2007-2011 79
Table 68: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Japan, Revenue Forecast ($m), 2011-2018 79
Table 69: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, the US, Cost of Vaccination ($), 2007-2011 80
Table 70: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, the US, Cost of Vaccination Forecast ($), 2011-2018 80
Table 71: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007-2011 80
Table 72: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011-2018 80
Table 73: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Japan, Cost of Vaccination ($), 2007-2011 81
Table 74: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Japan, Cost of Vaccination Forecast ($), 2011-2018 81
Table 75: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Global, Pipeline by Phase, 2012 83
Table 76: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, the US, Revenue ($m), 2007-2011 86
Table 77: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, the US, Revenue Forecast ($m), 2011-2018 86
Table 78: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, Top Five European Countries, Revenue ($m), 2007-2011 87
Table 79: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, Top Five European Countries, Revenue Forecast ($m), 2011-2018 88
Table 80: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, the US, Cost of Vaccination ($), 2007-2011 88
Table 81: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, the US, Cost of Vaccination Forecast ($), 2011-2018 88
Table 82: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007-2011 89
Table 83: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011-2018 89
Table 84: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, the US, Revenue ($m), 2007-2011 91
Table 85: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, the US, Revenue Forecast ($m), 2011-2018 91
Table 86: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, the UK, Revenue Forecast ($m), 2011-2018 91
Table 87: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, the US, Cost of Vaccination ($), 2007-2011 91
Table 88: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, the US, Cost of Vaccination Forecast ($), 2011-2018 91
Table 89: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, the UK, Cost of Vaccination Forecast ($), 2012-2018 92
Table 90: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, Global, Pipeline by Phase, 2012 92
Table 91: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, the US, Revenue ($m), 2007-2011 94
Table 92: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, the US, Revenue Forecast ($m), 2011-2018 94
Table 93: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Top Five European Countries, Revenue ($m), 2007-2011 95
Table 94: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Top Five European Countries, Revenue Forecast ($m), 2011-2018 95
Table 95: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Japan, Revenue ($m), 2007-2011 96
Table 96: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Japan, Revenue Forecast ($m), 2011-2018 96
Table 97: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, the US, Cost of Vaccination ($), 2007-2011 97
Table 98: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, the US, Cost of Vaccination Forecast ($), 2011-2018 97
Table 99: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Top Five European Countries, Cost of Vaccination ($), 2007-2011 97
Table 100: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011-2018 97
Table 101: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Japan, Cost of Vaccination ($), 2007-2011 98
Table 102: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Top Five European Countries, Cost of Vaccination Forecast ($), 2011-2018 98
Table 103: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Global, Pipeline by Phase, 2012 98

1.2 List of Figures
Figure 1: Adult and Adolescent Vaccines Market to 2018, Global, Types of Vaccines, 2012 16
Figure 2: Adult and Adolescent Vaccines Market to 2018, The US, Recommendations for Immunization (19-65+ Years), 2012 17
Figure 3: Adult and Adolescent Vaccines Market to 2018, the US, Recommendations for Immunization (7-18 Years), 2012 18
Figure 4: Adult and Adolescent Vaccines Market to 2018, Top Five European Countries, Recommendations for Immunization, 2012 19
Figure 5: Adult and Adolescent Vaccines Market to 2018, Japan, Recommendations for Immunization (Under 20 Years of Age), 2011 20
Figure 6: Adult and Adolescent Vaccines Market to 2018, Global, Vaccine Manufacturing Process, 2012 24
Figure 7: Adult and Adolescent Vaccines Market to 2018, Top Seven Markets, Revenue Forecast ($bn), 2007-2018 25
Figure 8: Adult and Adolescent Vaccines Market to 2018, Top Seven Markets, Market Share by Type of Vaccines (%), 2011 27
Figure 9: Adult and Adolescent Vaccines Market to 2018, Top Seven Markets, Market Share by Geography (%), 2011 28
Figure 10: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, the US, Revenue Forecast ($m), 2007-2018 32
Figure 11: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Top Five European Countries, Revenue Forecast ($m), 2007-2018 34
Figure 12: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Japan, Revenue Forecast ($m), 2007-2018 36
Figure 13: Adult and Adolescent Vaccines Market to 2018, Influenza Vaccines, Global, Pipeline by Phase (%), 2012 39
Figure 14: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, the US, Revenue Forecast ($m), 2007-2018 43
Figure 15: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Top Five European Countries, Revenue Forecast ($m), 2007-2018 44
Figure 16: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Japan, Revenue Forecast ($m), 2007-2018 46
Figure 17: Adult and Adolescent Vaccines Market to 2018, Td/Tdap, Global, Pipeline by Phase (%), 2012 49
Figure 18: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, the US, Revenue Forecast ($m), 2007-2018 51
Figure 19: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Top Five European Countries, Revenue Forecast ($m), 2007-2018 53
Figure 20: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Japan, Revenue Forecast ($m), 2007-2018 55
Figure 21: Adult and Adolescent Vaccines Market to 2018, Pneumococcal Vaccines, Global, Pipeline by Phase (%), 2012 58
Figure 22: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, the US, Revenue Forecast ($m), 2007-2018 61
Figure 23: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, Top Five European Countries, Revenue Forecast ($m), 2007-2018 62
Figure 24: Adult and Adolescent Vaccines Market to 2018, Meningococcal Vaccines, Global, Pipeline by Phase (%), 2012 65
Figure 25: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, the US, Revenue Forecast ($m), 2007-2018 67
Figure 26: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Top Five European Countries, Revenue Forecast ($m), 2007-2018 68
Figure 27: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Japan, Revenue Forecast ($m), 2010-2018 70
Figure 28: Adult and Adolescent Vaccines Market to 2018, HPV Vaccines, Global, Pipeline by Phase (%), 2012 73
Figure 29: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, the US, Revenue Forecast ($m), 2007-2018 76
Figure 30: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Top Five European Countries, Revenue Forecast ($m), 2007-2018 77
Figure 31: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Japan, Revenue Forecast ($m), 2007-2018 79
Figure 32: Adult and Adolescent Vaccines Market to 2018, Hepatitis Vaccines, Global, Pipeline by Phase (%), 2012 82
Figure 33: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, the US, Revenue Forecast ($m), 2007-2018 86
Figure 34: Adult and Adolescent Vaccines Market to 2018, MMR Vaccines, Top Five European Countries, Revenue Forecast ($m), 2007-2018 87
Figure 35: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, the US, Revenue Forecast ($m), 2007-2018 90
Figure 36: Adult and Adolescent Vaccines Market to 2018, Zoster Vaccines, Global, Pipeline by Phase (%), 2012 92
Figure 37: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, the US, Revenue Forecast ($m), 2007-2018 93
Figure 38: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Top Five European Countries, Revenue Forecast ($m), 2007-2018 94
Figure 39: Adult and Adolescent Vaccines Market to 2018, Varicella Vaccines, Japan, Revenue Forecast ($m), 2007-2018 96
Figure 40: Adult and Adolescent Vaccines Market to 2018, GSK, SWOT Analysis, 2012 100
Figure 41: Adult and Adolescent Vaccines Market to 2018, Sanofi, SWOT Analysis, 2012 101
Figure 42: Adult and Adolescent Vaccines Market to 2018, Pfizer, SWOT Analysis, 2012 102
Figure 43: Adult and Adolescent Vaccines Market to 2018, Merck, SWOT Analysis, 2012 103
Figure 44: Adult and Adolescent Vaccines Market to 2018, Novartis, SWOT Analysis, 2012 104
Figure 45: Adult and Adolescent Vaccines Market to 2018, Global, Strategic Consolidations, Deals by Year, 2009-2012 105
Figure 46: Adult and Adolescent Vaccines Market to 2018, Global, Strategic Consolidations, Deals by Type, 2009-2012 106
Figure 47: Adult and Adolescent Vaccines Market to 2018, Global, Strategic Consolidations, Deals by Value, 2009-2012 107
Figure 48: Adult and Adolescent Vaccines Market to 2018, Global, Strategic Consolidations, Deals by Geography, 2009-2012 108
Figure 49: GBI Research Market Forecasting Model 118

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Clare

+1 339 368 6001

Purchase Reports From Reputable Market Research Publishers

Antibiotics: Technologies and Global Markets

Antibiotics: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • May 2014
  • by BCC Research

Use this report to: - Identify the major market trends and the factors driving or inhibiting the growth of the global pharmaceutical antibiotics market and its various submarkets. - Learn about developments ...

Antifungal Drugs : Technologies and Global Markets

Antifungal Drugs : Technologies and Global Markets

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

This report aims to determine the current status of the global human antifungal market and assess its growth potential over the five-year period from 2013 through 2018. It covers approved human therapeutics ...

DNA Vaccines: Technologies and Global Markets

DNA Vaccines: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • July 2014
  • by BCC Research

This BCC Research study determines the specific applications and global market demand for DNA vaccine products over a five-year period from 2014 to 2019. High growth and market potential segments of the ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.